Metagenomic Sequencing Market Research Report- Forecast to 2030

Metagenomic Sequencing Market Research Report: By Technology (Sequencing, Bioinformatics) Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, Ecology, Agriculture) & ndash; Forecast To 2030

ID: MRFR/LS/4149-HCR | January 2023 | Region: Global | 90 Pages         

Metagenomic Sequencing Market Speak to Analyst Request a Free Sample

Metagenomic Sequencing Market

The global metagenomic sequencing market is expected to grow at a CAGR of approximately 17.20% during the forecast period 2022-2030.

By Technology Sequencing Bioinformatics
By Application Infectious Disease Diagnosis Environmental Remediation Gut Microbe Characterization Biotechnology Biofuel
Key Players
Companies Profiled   GATC Biotech AG (Germany)   Enterome Bioscience (France)   SciGenom Labs Pvt. Ltd. (India)   Second Genome Therapeutics (U.S.)   Quest Diagnostics Incorporated (U.S.)   Freenome Inc. (U.S.)   GenapSys Inc. (U.S.)   COSMOSID (U.S.)   Pacific Biosciences (U.S.)   Illumina Inc. (U.S.)
Market Driving Forces   Advanced technological platforms    Rising awareness of genetic disorders
Request a Free Sample

Metagenomic Sequencing Market Overview

The Metagenomic Sequencing Market is anticipated to reach USD 1,659.22 Million by 2030 at 17.20% CAGR during the forecast period 2022-2030. with a significant value. Metagenomic sequencing helps researchers for a comprehensive sample of all genes in organisms which is present in a complex sample. The method allows microbiologists to evaluate bacterial diversity and detect the abundance of microbes in different environments. The Market has been a greater benefit for all biotechnology and microbiology field researchers. 

The metagenomics technique has shown significant improvements in microbial evolution, ecology, and diversity, and it is mostly carried out in many research laboratories. The growth of advanced laboratories has become a boosting factor of the Metagenomic Sequencing Market Growth.

The technique has become more productive because it provides necessary information of all potential activities of microbes represented by metagenome rather than just a subset of those targeted by functional screening, allowing for scalability and independence from the availability of high-throughput screening systems.

The rise in awareness of disorders due to the genetic history is driving the Metagenomic Sequencing Market Size. The advanced platforms and improved genomic tools are the key growth factors that will accelerate the market during the forecast period.  

Moreover, the microorganisms’ genomic sequence has approached its dependence on existing gene annotations. It limits its ability to find fundamental novel genes for expressing required activities. The collection of large amounts of data in genetic databases and the development of advanced bioinformatics algorithms will encourage the use of sequencing-based metagenomics. These activities will propel the Metagenomic Sequencing Market Trends at the global level.

COVID-19 Analysis

During the pandemic period, almost every market faced economic loss at least once through the lockdown. Especially the industrial unit was hampered when the government announced to shut down in various regions. The Metagenomic Sequencing Market noticed you had shown mixed impact during the COVID-19 outbreak. 

In the early stage of the pandemic, the market faced a challenging situation when the players stopped the research and development activities and operations. The laboratory experiments were halted to stop the spread of the deadly virus. But in the future days of pandemics, when the scientists began to experiment on the virus to know about the variations through sequencing methods, it helped the market recover the loss. The demand increased with higher space among the research laboratories. This factor has helped the Metagenomic Sequencing Market Share to revive. In the coming days, there are even chances of new variants of the corona, due to which the market’s growth will remain consistent. 

Chief Factors Existing In The Market

  • Key Market Drivers

The growth factors are letting the Metagenomic Sequencing Market Outlook emerge with higher standards. The market has multiple driving factors that propel its growth rate. Advanced bioinformatics tools, novel drugs recovery, high throughput screening methods, and cost-effective technologies development are chiefly driving the market. Advancements in structural and functional metagenomics have led to the discovery of novel genes and metabolic pathways for bioactive molecules production with improved characteristics; this has become helpful to solve the problem of medication resistance and simultaneously drove the market’s demand.

  • Market Challenges

The Metagenomic Sequencing Market is facing various challenges which are affecting its growth demand. The pandemic was challenging, but the market successfully overcame the situation. The lack of experts and professionals in the industry is another challenging factor.

  • Market Opportunities

The rise in research and development activities for identifying newer antibiotics and enzymes is setting huge chances to expand the business of the top players. Improvement in bioinformatics and genetic engineering is offering lucrative opportunities for the market. 

  • Market Restraints

The Metagenomic Sequencing Market has some restraining factors that are limiting its growth during the progress. The rise in concern related to the standardization and lack of required accuracy of diagnostic testing is hampering the market’s growth. The lack of skilled professionals and knowledge on gene sequencing are other market constraints.

Cumulative Evaluation Of The Market

The Metagenomic Sequencing Market Analysis evaluation states that it will reach a good CAGR value in the forecast period. The overview status of the market proved the performance based on the presence of growth factors and other supportive strategies and ideas. The market dynamics play a magnificent role with their related effects. The challenges and constraints are hampering, but due to the presence of growth opportunities, the market will elevate. The starting days of the COVID-19 period were a bit tough for the market’s progress, but it eventually recovered from the loss. Therefore, the Market will achieve a strong value during the evaluation period. 

Market Segmentation

The Metagenomic Sequencing Market is segmented into technology, application, and end-user. These segments are further sub-segmented into different types. 

  • By Technology

The technology segment of the market is segregated into sequencing, bioinformatics, and others.

  • By Application

The application section of the market is fragmented into gut microbe characterization, biotechnology, infectious disease diagnosis, environmental remediation, biofuel, ecology, agriculture, and others

  • By End-User

The end-user segment is categorized into hospitals, research institutes, specialized clinics, and others.

Regional Analysis

According to geographical analysis, the Metagenomic Sequencing Market covers the prominent regions of the world such as the Americas, Europe, Asia Pacific, the Middle East and Africa.

The Americas region is the leading region due to the technological advancements in the next-generation sequencing procedures. The players are focusing on introducing procedures associated with innovative technologies. This is driving the regional market of the American region.

The European market is capturing the second-largest share of the market due to the higher investment by the hospitals and government for better healthcare facilities. Other factors accelerating the regional growth are collaborations and partnerships, lower cost of sequencing and rise in adoption of NGS procedure in research laboratories.

The Asia Pacific region will witness the fastest growth rate due to the increased rate of genetic disorders worldwide, which is boosting the growth of the market. Affordable healthcare and research operations are a major factor for the growth of the APAC market. The industrial payers also heavily invested in expanding their network in the business, which is driving the market. 

The Middle East and Africa are also anticipated to notice a healthy growth rate in the coming five years. But the market of this region is not maintaining the growth consistency because of lack of knowledge in genetic diseases and disorders, lack of proper healthcare facilities and research infrastructure, limited availability of products and services, cost of the tests etc. are hampering its growth.

Competitive Intensity Within The Industry 

The Metagenomic Sequencing Market is emerging due to the developments of industrial players. Their presence in prominent continents is propelling the market to reach a higher compound annual growth rate. The collaborations and mergers between the players are major reasons the market is elevating. The developments and upgradation are helping the market to maintain its growth consistency. The top players of the Market are mentioned below.

  • GATC Biotech AG (Germany)

  • Enterome Bioscience (France)

  • SciGenom Labs Pvt. Ltd. (India)

  • Second Genome Therapeutics (U.S.)

  • Quest Diagnostics Incorporated (U.S.)

  • Freenome Inc. (U.S.)

  • GenapSys, Inc. (U.S.)


  • Pacific Biosciences (U.S.)

  • Illumina Inc. (U.S.)

  • Aperiomics, Inc. (U.S.)

  • The Mitre Corporation (U.S.)

  • F Hoffman-La Roche Ltd. (Switzerland)

  • Beijing Genomics Institute (China)

  • Biomatters Ltd. (New Zealand)

  • Thermo Fisher Scientific Inc. (U.S.)

  • Oxford Nanopore Technologies Inc. (UK)

  • CLC Bio (Qiagen) (Denmark)

  • Agilent Technologies Inc. (U.S.)

  • DNAStar Inc. (U.S.)

  • Macrogen Inc. (South Korea)

  • HelicosBioSciences (U.S.)

  • Knome Inc. (U.S.)

Recent Market Developments

  • According to the current study, the researchers collected patient stool samples aged 18 years or older who were treated with ICIs for advanced cutaneous melanoma treatment between August 2015 and January 2020. These patients were classified as responders or non-responders based on the radiographic response. Overall response rates and progression-free survival at 12 months were used as clinical endpoints. Shotgun metagenomic sequencing was performed for collecting stool samples.¬†

  • In January 2019, KingMed Diagnostics (China) and Illumina partnered for co-developing the oncology and hereditary disease testing applications using Illumina‚Äôs NGS technology.

Report Overview

The complete overall report of the Metagenomic Sequencing Market shows that it has achieved a good growth rate in the past years, and it is estimated to successfully reach a great value. The driver and opportunities are helping the market to maintain its growth consistency despite the presence of challenging and restraining factors. The pandemic report has shown that the market has recovered and will continue its significant growth. The segments and regional analysis were also mentioned in the report briefly. The key players’ role, along with their development, was stated in detail. Hence, the study suggests that the Market will reach a good CAGR during the forecast period.

Key Industrial Segments

By Technology 

  • Sequencing

  • Bioinformatics

By Application 

  • Infectious Disease Diagnosis

  • Environmental Remediation

  • Gut Microbe Characterization

  • Biotechnology

  • Biofuel

  • Ecology

  • Agriculture

By End-User

  • Hospitals

  • Research Institutes

  • Specialized Clinics

  • Others

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Metagenomics sequencing, also known as environmental or community genomics, is a genomic study wherein the DNA of the specified host microorganism is extracted and cloned directly from the microorganism.

The market is expected to exhibit a strong 17.20% CAGR over the forecast period from 2022-2030.

The increasing research into genetics is likely to be a major driver for the market.

The Americas region dominates the global metagenomics sequencing market

Leading players in the metagenomics sequencing market include GATC Biotech, Enterome Bioscience, and Aperiomics, among others.